162 related articles for article (PubMed ID: 1516109)
1. Plasma platelet activating factor degradation and serum lipids after coronary bypass surgery.
Stephens CJ; Graham RM; Yadava OP; Leong LL; Sturm MJ; Taylor RR
Cardiovasc Res; 1992 Jan; 26(1):25-31. PubMed ID: 1516109
[TBL] [Abstract][Full Text] [Related]
2. Variation in plasma platelet-activating factor degradation and serum lipids after acute myocardial infarction.
Stephens CJ; Graham RM; Sturm MJ; Richardson M; Taylor RR
Coron Artery Dis; 1993 Feb; 4(2):187-93. PubMed ID: 8269210
[TBL] [Abstract][Full Text] [Related]
3. Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis.
Graham RM; Stephens CJ; Silvester W; Leong LL; Sturm MJ; Taylor RR
Crit Care Med; 1994 Feb; 22(2):204-12. PubMed ID: 8306677
[TBL] [Abstract][Full Text] [Related]
4. Plasma platelet-activating factor degradation in patients with severe coronary artery disease.
Graham RM; Stephens CJ; Sturm MJ; Taylor RR
Clin Sci (Lond); 1992 May; 82(5):535-41. PubMed ID: 1317763
[TBL] [Abstract][Full Text] [Related]
5. Effects of estrogen and progesterone on plasma platelet-activating factor-acetylhydrolase activity and low-density lipoprotein cholesterol concentration in men.
Ohshige A; Ito M; Koyama H; Maeda T; Yoshimura T; Okamura H
Artery; 1996; 22(3):115-24. PubMed ID: 8893970
[TBL] [Abstract][Full Text] [Related]
6. Platelet aggregability to platelet activating factor at rest and after exercise in patients with coronary artery disease.
Goudevenos J; Tselepis AD; Tsoukatos D; Grekas G; Kritikakos J; Sideris D
Eur Heart J; 1995 Aug; 16(8):1036-43. PubMed ID: 8665964
[TBL] [Abstract][Full Text] [Related]
7. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase.
Tselepis AD; John Chapman M
Atheroscler Suppl; 2002 Dec; 3(4):57-68. PubMed ID: 12573364
[TBL] [Abstract][Full Text] [Related]
8. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
Milionis HJ; Elisaf MS; Karabina SA; Bairaktari E; Tselepis AD; Siamopoulos KC
Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
[TBL] [Abstract][Full Text] [Related]
9. The metabolism of platelet-activating factor in severe and cerebral malaria.
Davis TM; Binh TQ; van Phuong N; Sturm M; St John A; Dyer JR; Anh TK
J Infect; 1995 Nov; 31(3):181-8. PubMed ID: 8586836
[TBL] [Abstract][Full Text] [Related]
10. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease.
Satoh K; Imaizumi T; Kawamura Y; Yoshida H; Takamatsu S; Mizono S; Shoji B; Takamatsu M
Prostaglandins; 1988 May; 35(5):685-98. PubMed ID: 3399678
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor and lipid metabolism in acute malaria.
Davis TM; Sturm M; Zhang YR; Spencer JL; Graham RM; Li GQ; Taylor RR
J Infect; 1993 May; 26(3):279-85. PubMed ID: 8505562
[TBL] [Abstract][Full Text] [Related]
12. Excretion of platelet activating factor-acetylhydrolase and phospholipase A2 into nasal fluids after allergenic challenge: possible role in the regulation of platelet activating factor release.
Touqui L; Herpin-Richard N; Gene RM; Jullian E; Aljabi D; Hamberger C; Vargaftig BB; Dessange JF
J Allergy Clin Immunol; 1994 Jul; 94(1):109-19. PubMed ID: 8027488
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E
Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095
[TBL] [Abstract][Full Text] [Related]
14. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.
Stafforini DM; McIntyre TM; Carter ME; Prescott SM
J Biol Chem; 1987 Mar; 262(9):4215-22. PubMed ID: 3549727
[TBL] [Abstract][Full Text] [Related]
15. Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus.
Kujiraoka T; Iwasaki T; Ishihara M; Ito M; Nagano M; Kawaguchi A; Takahashi S; Ishi J; Tsuji M; Egashira T; Stepanova IP; Miller NE; Hattori H
J Lipid Res; 2003 Oct; 44(10):2006-14. PubMed ID: 12867534
[TBL] [Abstract][Full Text] [Related]
16. Effects of antihypertensive and hypolipidemic drugs on plasma and high-density lipoprotein-associated platelet activating factor-acetylhydrolase activity.
Tambaki AP; Rizos E; Tsimihodimos V; Tselepis AD; Elisaf M
J Cardiovasc Pharmacol Ther; 2004 Jun; 9(2):91-5. PubMed ID: 15309245
[TBL] [Abstract][Full Text] [Related]
17. Acrylyl-PAF, a synthetic platelet-activating factor analogue.
Duffy-Krywicki RH; Steinhelper ME; Olson MS
J Lipid Mediat; 1991; 3(3):345-59. PubMed ID: 1773032
[TBL] [Abstract][Full Text] [Related]
18. Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma.
Stafforini DM; Carter ME; Zimmerman GA; McIntyre TM; Prescott SM
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2393-7. PubMed ID: 2928339
[TBL] [Abstract][Full Text] [Related]
19. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers.
Imaizumi T; Satoh K; Yoshida H; Kawamura Y; Hiramoto M; Koyanagi M; Takamatsu S; Takamatsu M
Heart Vessels; 1990; 5(2):81-6. PubMed ID: 2354992
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor acetylhydrolase activity in bovine seminal plasma.
Parks JE; Hough SR
J Androl; 1993; 14(5):335-9. PubMed ID: 8288488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
